基于京都分类的预测因素与胃癌的发展相关的Helicobacter pylori根除后:一个前性的多中心观察研究
Shun Takayama1, Osamu Dohi1, Ryusuke Horie2
1Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
Diagnostics (Basel, Switzerland)
|September 27, 2025
概括
类似地图的红色和收集静脉 (RAC) 的隐形正规排列是预测H. pylori根除后胃癌 (GC) 的关键内镜发现. 这些指标在一年内出现,突显了早期监测的必要性.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 内镜检查是指内镜检查.
背景情况:
- 胃癌 (GC) 仍然是全球重要的健康问题.
- 杆菌 (H. pylori) 感染是GC的主要危险因素.
- 成功根除 H. pylori 是至关重要的,但并不能完全消除 GC 的风险.
研究的目的:
- 为了确定预测H. pylori根除后GC发展的特定内镜发现.
- 使用京都胃炎分类来分析内镜特征和GC发病率之间的关联.
- 为了在H. pylori根除后的患者中建立GC的早期预测指标.
主要方法:
- 未来的多中心观察性研究.
- 包括接受年度监测内镜后H. pylori根除 (2013年9月 - 2019年6月) 的患者.
- 使用京都胃炎分类对内镜检测结果的分析.
主要成果:
- 包括465名患者;49人发展了GC.
- 图像般的红色 (HR 2.561) 和隐形的RAC (HR 3.131) 被确定为独立的GC预测因素.
- 显著更高的GC发病率在患有地图状红色或隐形RAC (p < 0.001) 的患者中.
- 在根除后一年内,在13%和28.4%的患者中观察到类似地图的红色和可见的RAC.
结论:
- 类似地图的红色和看不见的RAC是H. pylori根除后GC的重要独立预测因素.
- 这些内镜检测结果是高瘤风险的早期指标.
- 早期监测内镜对于在根除后识别高风险患者至关重要.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
538
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
538
Peptic Ulcer Disease I: Introduction
745
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
745
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.1K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K


